1. The obligation for each party to grant mutual recognition under a sectoral annex of this agreement is conditional on the continuation of the activities of the other party. As part of this bilateral agreement, approved by the European Union on October 28, 2016, the European Union and Canada accept compliance assessments, carried out by notified bodies for certain industrial products. The MRA with Israel is an agreement on the evaluation of compliance and acceptance of industrial products (ACAA). It is a specific type of MRI based on the alignment of the legal system and infrastructure of the country concerned with that of the EU. I would like to take into account one of the aspects that I feel less debated: the “MRA” agreements on mutual recognition of professions. The MRA, which falls under Chapter 11 of CETA, will be part of the interim application, as confirmed by the ECJ, and it may be interesting for our profession to be analyzed in detail. The aim of the MRA is to support mutual recognition of professional qualifications such as doctors, architects, accountants, engineers between Canada and the EU and to support integration between the two blocs. Currently, strictly for accountants, there are already some MRAs between the CPA and local EU bodies, but these are bilateral agreements negotiated between the CPA of Canadian Province X and the local body of the EU country Y. Even nationally recognized organizations can vary province by province, for example the Institute of Auditors of India is recognized in Ontario, but not in Quebec. The fact that professional qualifications fall under provincial jurisdiction (for Canada) and the jurisdiction of Member States for the EU complicates the application of Chapter 11. In practical terms, since the EU and the federal government are not responsible for professional organisations, CETA cannot compel regulators in the various Member States/provinces to negotiate and sign DEEE ACCORDS. What CHAPTER 11 of CETA does is two important things: 1.
Encourage, if necessary, their competent authorities or professional organizations to develop and establish joint mutual recognition committees (Article 11.3.1) 2. (Art. 11.3.2-6) During a transitional period, the authorities assess each other`s pharmaceutical legislation, guidelines and regulatory systems under the agreement.